Terns seeks a partner for its oral metabolic programs; Jazz delays Phase 3 readoutnews2025-08-06T14:54:59+00:00August 6th, 2025|Endpoints News|
Merck was the only bidder for Verona before the $10B buyoutnews2025-08-06T14:49:23+00:00August 6th, 2025|Endpoints News|
Bayer has laid off 12,000 staffers so far — with more to comenews2025-08-06T11:08:59+00:00August 6th, 2025|Endpoints News|
Novo Nordisk’s pipeline cull prompts hopes of strategic shiftnews2025-08-06T10:39:45+00:00August 6th, 2025|Endpoints News|
AstraZeneca culls plans for Evusheld successor in the US following Covid evolutionnews2025-08-06T01:29:00+00:00August 6th, 2025|Endpoints News|
Kennedy says BARDA will cancel 22 mRNA vaccine contractsnews2025-08-05T23:01:56+00:00August 5th, 2025|Endpoints News|
Makary has asked Prasad to ‘reconsider’ departure from FDAnews2025-08-05T18:25:32+00:00August 5th, 2025|Endpoints News|
Specialty pharma SERB to buy Y-mAbs in $412M all-cash dealnews2025-08-05T18:17:35+00:00August 5th, 2025|Endpoints News|
Novartis’ Entresto faces first US generic competitorsnews2025-08-05T17:59:12+00:00August 5th, 2025|Endpoints News|
Beam delays key AATD readout, reveals plans to dose patients twicenews2025-08-05T17:58:24+00:00August 5th, 2025|Endpoints News|
